Stay updated with breaking news from Abbott ultreon. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Frost and Sullivan According to a recent report by international growth partnership company Frost and Sullivan, Western Europe’s medical device market is on track to recover from the COVID-19 pandemic by 2023. The report, titled ‘Impact of COVID-19 on Elective Procedures in Western Europe, 2020–2023’, projects that the market for selective medical devices for elective procedures will reach $16.8 billion (€13.76B) by 2023. according to an aspirational compound annual growth rate of 29.2%. WHY IT MATTERS Because of COVID-19, there was a 45.5% decline in the selective medical devices market for elective procedures from the pre-COVID projections for 2020. However, the restrictions and challenges raised by the pandemic have forced medical device manufacturers to think in new ways, creating growth opportunities in the sector. ....
Journal of the American College of Cardiology) Stroke survivors trying to regain arm function in rehabilitation found incremental improvement with vagus nerve stimulation in the VNS-REHAB trial. ( The Lancet) The American College of Physicians released a guideline on the use of point-of-care ultrasound for patients with acute dyspnea. A theory posits that dual SGLT1 and SGLT2 inhibition could improve cardiovascular outcomes for people with diabetes. ( Circulation) Philips Stellarex paclitaxel drug-coated balloon did not increase deaths at 5 years over percutaneous transluminal angioplasty in a 600-patient meta-analysis supporting its safety. Clotting drug tranexamic acid did not raise complication rates for high-risk patients undergoing orthopedic surgeries. ( ....